TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING PHYSOSTIGMINE AS ACTIVE COMPONENT
HANS - RAINER HOFFMANN, HANS- JOACHIM HUBER, AXEL, KNOCH, GERHARD, SCHNEIDER, THOMAS, HILLE, FRITZ, STANISLAUS
Year of Publication 21.12.1995
Get full text
Year of Publication 21.12.1995
Patent
TRANSDERMAL THERAPEUTIC SYSTEM WITH PHYSOSTIGMINE AS ACTIVE COMPONENT
HANS - RAINER HOFFMANN, AXEL, KNOCH, HANS - JOACHIM HUBER, THOMAS, HILLE, GERBARD, SCHNEIDER, FRITZ, STANISLAUS
Year of Publication 21.12.1995
Get full text
Year of Publication 21.12.1995
Patent
When are bioavailability studies required? A German proposal
Gleiter, C H, Klotz, U, Kuhlmann, J, Blume, H, Stanislaus, F, Harder, S, Paulus, H, Poethko-Müller, C, Holz-Slomczyk, M
Published in Journal of clinical pharmacology (01.10.1998)
Published in Journal of clinical pharmacology (01.10.1998)
Get more information
Journal Article
Pharmacokinetics of nilvadipine
von Nieciecki, A, Huber, H J, Stanislaus, F
Published in Journal of cardiovascular pharmacology (1992)
Published in Journal of cardiovascular pharmacology (1992)
Get more information
Journal Article